SUN

Surgical Innovations Group PLC

Health Care First-pass screen £4.20m

310/1000 Overall fit

AI beneficiary 35% 22

Operating leverage 25% 36

Valuation 25% 30

Downside protection 15% 47

First-pass take

Loss-making micro-cap medical device manufacturer with zero AI exposure. Defensive healthcare positioning and low leverage (15% debt/equity) provide downside protection, but deteriorating EBITDA (−£0.4m vs +£0.05m), flat revenues, and active board strategic review signal material distress.

Flags

no-valuation-dataloss-makingnegative-ebitdastrategic-reviewmicro-capzero-ai-exposurecustomer-concentrationmanufacturingboard-turnover